Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lantheus Holdings Inc LNTH

Healthcare Medical Instruments & Supplies
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

GlobeNewswire 1 day ago

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

GlobeNewswire March 5, 2024

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

GlobeNewswire March 4, 2024

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

GlobeNewswire February 28, 2024

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire February 26, 2024

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 22, 2024

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

GlobeNewswire February 13, 2024

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

GlobeNewswire February 8, 2024

Lantheus Announces CEO Succession Plan

GlobeNewswire January 23, 2024

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)

GlobeNewswire January 11, 2024

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

GlobeNewswire January 9, 2024

Lantheus Reports Preliminary Fiscal Year 2023 Revenue

GlobeNewswire January 9, 2024

Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2024

Lantheus to Present at the Jefferies London Healthcare Conference

GlobeNewswire November 8, 2023

Lantheus Reports Third Quarter 2023 Financial Results

GlobeNewswire November 2, 2023

Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern Time

GlobeNewswire October 19, 2023

Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI(TM) at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting

GlobeNewswire September 1, 2023

Lantheus to Present at the Wells Fargo Healthcare Conference

GlobeNewswire August 31, 2023

Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty

GlobeNewswire August 3, 2023

Lantheus Reports Second Quarter 2023 Financial Results

GlobeNewswire August 3, 2023